natgillin/translations-raw huggingface dataset:
Den gennemsnitlige højeste tidligere imatinib- dosis havde været 600 mg/ dag for CP- patienter og 800 mg/ dag for AP- patienter.
The median highest prior imatinib dose had been 600 mg/ day for CP patients and 800 mg/ day for AP patients.
Den højeste tidligere imatinib- dosis var ≥600 mg/ dag hos 75%, hvor 41% af patienterne modtog imatinib- doser ≥800 mg/ dag.
The highest prior imatinib dose was ≥ 600 mg/ day in 75% of all patients, with 41% of patients receiving imatinib doses ≥ 800 mg/ day.
CML- sygdomskarakteristika
CML disease history characteristics
Kronisk CLM (n=320)
Chronic phase (n=320)
Accelereret CLM (n=119)
Accelerated phase (n=119)
Gennemsnitlig tid siden diagnose
Median time (range) Imatinib
Resistent Intolerant uden MCyR
Resistant Intolerant without MCyR time of imatinib treatment in
96 (81%) 23 (19%)
96 23
Gennemsnitlig behandlingstid med
(81%) (19%) 976
imatinib i dage (25 - og 75- percentil)
days (25th-75th percentiles)
(515- 1. 485)
(515-1,485)
(488- 1. 543)
(488-1,543)
Tidligere hydroxyurea Tidligere interferon Tidligere knoglemarvstransplantation
Prior hydroxyurea Prior interferon Prior bone marrow transplant
83% 64% 8%
83% 64% 8%